Diseases of mitotic cell cycle
Sarek G, Marzec P, Margalef P, Boulton SJ. Molecular basis of telomere dysfunction in human genetic diseases. Nature Structural & Molecular Biology. 2015 Nov 04;22(11):867–74. doi: 10.1038/nsmb.3093.; Diaz-Moralli S, Tarrado-Castellarnau M, Miranda A, Cascante M. Targeting cell cycle regulation in cancer therapy. Pharmacol Ther. 2013 May;138(2):255–71. doi: 10.1016/j.pharmthera.2013.01.011. PMID: 23356980.; Webber KM, Raina AK, Marlatt MW, Zhu X, Prat MI, Morelli L, Casadesus G, Perry G, Smith MA. The cell cycle in Alzheimer disease: A unique target for neuropharmacology. Mechanisms of Ageing and Development. 2005 Oct;126(10):1019–25. doi: 10.1016/j.mad.2005.03.024.; Collins I, Garrett MD. Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Curr Opin Pharmacol. 2005 Aug;5(4):366–73. doi: 10.1016/j.coph.2005.04.009. PMID: 15964238.; Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer. 2002 Dec;2(12):910–7. doi: 10.1038/nrc950. PMID: 12459729.